Weber Shandwick Strengthens Expanding Healthcare Practice in Japan, Names Kazuhiro Hoshi Senior Vice President 

“We’re very pleased to have an opportunity to bring Kazuhiro to Weber Shandwick,” said Kubo. “Our healthcare practice will continue to be a pivotal area of our business, particularly in light of Japan’s aging society and the growing elderly population in China. As such, we’ve taken strategic measures to ensure we meet the unique needs of our healthcare clients, both domestically and internationally. Kazuhiro’s knowledge and position as industry leader make him the ideal complement to an already impressive team under Jeffrey.”

 

Hoshi comes to the firm with over 20 years of Japanese pharmaceutical-based communication experience. Before joining Weber Shandwick, Hoshi served as director of corporate communications for the Japan operations of Janssen Pharmaceutical, a subsidiary of global pharmaceutical giant, Johnson & Johnson. For almost a decade, he led the company’s communication strategy, media relations, risk management and corporate social responsibility programs. While working at Janssen Pharmaceutical, Kazuhiro was also a member of the Communication Committee and Chairman of the Patient Group Relations Team of the Japan Pharmaceutical Manufacturing Association.

 

Prior to serving as corporate communications director, Hoshi established Janssen’s internal communication function and developed in-house capabilities across core corporate communications disciplines including media relations, corporate advertising, production, and recruitment PR.

 

Speaking on his appointment, Hoshi commented, “I am truly delighted to begin the next phase of my career with the world-leading communication specialists at Weber Shandwick. I look forward to working alongside Jeffrey to help our local and global healthcare clients grow their businesses at home and abroad.”